Biogen Inc. (NASDAQ:BIIB)

Tuesday, July 21, 2009 | Web News
Biogen has updated its previously issued guidance. FULL YEAR 2009 Guidance Ending December a >Source: See Release, July 16, 2009....
Thursday, June 25, 2009 | Web News
Biogen Idec confirmed full year 2009 financial guidance outlined in February this year, consistent with achieving the Company’s 2010 financial goals
Saturday, February 14, 2009 | Web News
Guidance Report: Full Year Fiscal 2009 Guidance Ending December > *Non-GAAP EPS Figures exclude non-operating gains and losses....
See All Research...

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.

Web site:

Last updated March 5, 2008